TRPM8 antagonist 4 prodrug (Compound 8b) is an orally active CB2R agonist (EC50: 51.2 nM) and a weak TRPM8 antagonist. It acts as a prodrug of TRPM8 antagonist 4, exhibiting anti-inflammatory and analgesic properties. TRPM8 antagonist 4 prodrug is applicable in studies of inflammation-related pain disorders.
Target-Kategorie:
Others|||TRP/TRPV Channel|||Cannabinoid Receptor
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
